#OxfordGate Articles Published in Australia & the UK
“This is your Darkest Hour, Boris: let’s have some real leadership. Without that, God help us all.” While the #OxfordGate #RecoveryGate #CovidPapers story is still
Category: Noteworthy News
Quebec Continues to Reject HCQ Early Treatment; #LancetGate Fake Research Cited in Report
The governmental research institute of the Canadian province of Quebec, the INESSS, published on June 15 an update to its position on chloroquine / hydroxychloroquine.
Oxford COVID-19 Research Praised by Boris Johnson, Blasted by France-Soir
At a media conference this Tuesday, COVID-19 survivor and UK prime minister Boris Johnson announced “the biggest breakthrough yet” regarding therapies for the coronavirus. THIS
Oxford Academics Claim to Have Found First Drug Improving COVID-19 Survival, but Did They?
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, Professor of Emerging Infectious
FDA Terminates Hydroxychloroquine Emergency Authorization for COVID-19
Despite therapeutic successes with hydroxychloroquine around the world, and significant usage by many doctors in the US, who regularly report success in using the drug,
The UK Therapeutic Approach to COVID-19 is Flawed, Yet It Can Still be Rectified
This article, published (in English and French) in the leading online French newspaper France Soir, asserts that the UK therapeutic approach to COVID-19 is flawed,
Healthcare Workers Protected by HCQ Prophylaxis – Study
The study “Pre-exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers, by Bhattacharya and collaborators, found efficacy in pre-exposure prophylaxis for medical
Azithromycin in the Crosshairs of French Health Minister; Doctors to be Heard by Professional Order for Prescribing It
The generic antibiotic azithromycin, one of the world’s essential medicines according to the World Health Organization, is now in the crosshairs of French health minister
Oxford Research: Hydroxychloroquine Out; Remdesivir In
Little noticed was an announcement on May 27 by the Oxford RECOVERY trial that Remdesivir was now available for those participating in the trial, encompassing
Oxford Professor Horby Claims Professor Landray was Misquoted – France-Soir Newspaper Denies It
While the hydroxychloroquine arm of the RECOVERY Randomized Clinical Trial was terminated last Friday, the research continues to make waves in the French media, seemingly
Early Treatment for COVID-19 as Implemented by General Practitioners in France
General practitioners and specialized doctors operating outside hospital settings played a key role in the fight against COVID-19 in France. There are over 100,000 of
A Highly Viral Video by the Oxford RECOVERY Trial?
There is a video on YouTube showing how to seek consent from volunteer patients to participate in the RECOVERY trial. The video, which serves as
